Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4
|
| pubmed:dateCreated |
1990-9-27
|
| pubmed:abstractText |
Six patients with prostatic carcinoma, including 2 with Stage B, 2 with Stage C, 2 with Stage D1, received transurethral irradiation (TUI) using 60Co high dose rate, remote afterloading methods, in combination with external irradiation by 4 MV X-ray. Total tumor doses were 97.0 to 129.3 in TDF and needle biopsy performed 3 mo after the treatment proved to be free of cancer cell in 5 patients and almost no viable cancer cell in one patient. No adverse reactions were encountered in any patient. We believe that TUI is a useful treatment for prostatic carcinoma.
|
| pubmed:language |
jpn
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Apr
|
| pubmed:issn |
0048-0428
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
25
|
| pubmed:volume |
50
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
429-31
|
| pubmed:dateRevised |
2011-7-26
|
| pubmed:meshHeading |
pubmed-meshheading:2388814-Aged,
pubmed-meshheading:2388814-Brachytherapy,
pubmed-meshheading:2388814-Cobalt Radioisotopes,
pubmed-meshheading:2388814-Humans,
pubmed-meshheading:2388814-Male,
pubmed-meshheading:2388814-Middle Aged,
pubmed-meshheading:2388814-Prostatic Neoplasms,
pubmed-meshheading:2388814-Radiotherapy Dosage
|
| pubmed:year |
1990
|
| pubmed:articleTitle |
[Brachytherapy of prostatic carcinoma, 60Co high dose rate, remote after-loading methods].
|
| pubmed:affiliation |
Department of Radiology, Tokyo Metropolitan Komagome Hospital.
|
| pubmed:publicationType |
Journal Article,
English Abstract,
Research Support, Non-U.S. Gov't
|